Kestra Total Current Assets from 2010 to 2026

Stocks . USA . 
Stock . Kestra Medical Technologies
KMTS Stock   22.14  -0.15  -0.67%   
Total Current Assets are reflecting a rebounding pattern with measured volatility. Estimates place it near approximately 308.3 M for the current fiscal year. Total Current Assets is the total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle. View All Fundamentals
 
Total Current Assets  
 First Reported
2010-12-31
 Previous Quarter
293.6 M
 Current Value
308.3 M
 Quarterly Volatility
109 M
Macro event markers
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
This statements view for Kestra Medical organizes long-term performance signals with capital structure context. The series highlights drivers like Tax Provision of 81.4 K, Depreciation And Amortization of 5.6 M or Interest Expense of 4.6 M and ratios such as Price To Sales Ratio of 21.77, Dividend Yield of 0.0013 or PTB Ratio of 6.34, complementing Kestra Medical Valuation and Volatility.
  
Build AI portfolio with Kestra Stock
Compare Kestra Medical against competitors using Kestra Medical Correlation. This supports competitive context.
The evolution of Total Current Assets for Kestra Medical Technologies provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Kestra Medical compares to historical norms and industry peers.

Latest Kestra Medical's Total Current Assets Growth Pattern

Below is the plot of the Total Current Assets of Kestra Medical Technologies over the last few years. It is the total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle. Kestra Medical's Total Current Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Kestra Medical's overall financial position and show how it may be relating to other accounts over time.
Total Current Assets10 Years Trend
Slightly volatile
Compare to OthersAll Fundamentals
   Total Current Assets   
       Timeline  

Kestra Total Current Assets Regression Statistics

Arithmetic Mean 58,640,751
Geometric Mean 15,822,485
Coefficient Of Variation 185.82
Mean Deviation 80,157,824
Median 6,168,000
Standard Deviation 108,964,631
Sample Variance11873.3T
Range302.1M
R-Value 0.69
Mean Square Error6597.1T
R-Squared 0.48
Significance 0.0021
Slope 14,935,870
Total Sum of Squares189972.7T

Kestra Total Current Assets History

2026308.3 M
2025293.6 M
2024255.3 M
202314.9 M
202118.4 M
202026.2 M

About Kestra Medical Technologies, Ltd. Common Stock

Kestra Medical is publicly available via the NASDAQ Exchange. Downside history and drawdown behavior provide context for risk expectations in Kestra Medical. Downside profile remains relatively contained. Kestra Medical has a market cap of 1.3 B, ROE of -126.4%.

Methodology

Unless otherwise specified, financial data for Kestra Medical Technologies is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Kestra (USA Stocks:KMTS) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Macroaxis analytics incorporate public filings and market reference sources and official disclosures from U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA). Data harmonization may result in minor timing offsets. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Kestra Medical Technologies is covered by 7 analysts. 3 analysts have submitted revenue and/or earnings estimates that may be incorporated into Macroaxis consensus inputs where available. Representative analyst firms may include Jefferies, Raymond James, Goldman Sachs, Bank of America Securities, Morgan Stanley, Deutsche Bank, Wells Fargo Securities, among others. Updates may occur throughout the day.

Kestra Stock is Curated By:

Raphi ShpitalnikRaphi Shpitalnik ยท Junior Member of Macroaxis Editorial Board

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Kestra Stock Analysis

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Commodity Directory
Find actively traded commodities issued by global exchanges
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Fundamental Analysis
View fundamental data based on most recent published financial statements
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY